Article

Measures to Assess Hospital Quality Are Flawed, Study Finds

Author(s):

The approach for assessing hospital penalties under the Hospital-Acquired Condition Reduction Program might need to be reconsidered in order to achieve the intended goal of the program.

approach for assessing hospital penalties under the

Hospital-Acquired Condition (HAC) Reduction Program might need to be reconsidered in order to achieve the intended goal of the program, according to findings published in JAMA.

relationship between the hospital quality summary score and HAC program penalization as well as publicly reported process-of-care and outcome measures from 4 clinical areas: surgery, acute myocardial infarction, heart failure, and pneumonia.

The findings of the study showed hospitals were more likely to be penalized if they had accreditations, offered advanced services, were major teaching institutions or performed better on other quality measures.

reduces payments to the lowest-performing hospitals, and researchers examined the

The HAC Reduction Program

The

“Higher-performing hospitals were penalized more because some of the measures that CMS uses to assess quality are flawed,” senior author Karl Bilimoria, MD, assistant professor in surgery-surgical oncology and director of the Surgical Outcomes and Quality Improvement Center, said in a statement. “The measures paradoxically identify high-performing hospitals as poor performers. Clearly this is not ideal for hospitals or for patients.”

ospitals with the highest quality score of 8 were penalized significantly more frequently than hospitals with the lowest quality score of 0.

Nearly one-fourth (22%) of participating hospitals were penalized and h

See the study: http://bit.ly/1PfhkJH

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center
Coral Omene, MD, PhD, sitting for a vieo interview
David Awad, PharmD, BCOP
Screenshot of Coral Omene, MD, PhD
Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center
Ali Khawar
Eileen Peng, PharmD, sitting for a video interview
Ali Khawar
Eileen Peng, PharmD, sitting for a video interview
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo